Skip to main content
. 2009 Feb 25;9:9. doi: 10.1186/1472-6807-9-9

Table 2.

GAPDH complexes with substrate or substrate analogue.

PDB number Reference NAD present Substrate No. of subunits with substrate Ps or New Pi* site Soaked or Co-crystallized
CpGAPDH This structure Yes D-glyceraldehyde 3-phosphate 4 New Pi& Co-crystal
1GYP 17 Yes PO4 4 Ps and new Pi Co-crystal
1DC4 16 No D-glyceraldehyde 3-phosphate 2# New Pi Soaked
1NQO 15 Yes D-glyceraldehyde 3-phosphate 4 Ps Soaked
3CMC 12 Yes D-glyceraldehyde 3-phosphate 4 New Pi Soaked
1ML3 14 Yes (3-formyl-but-3-enyl)-phosphonic acid 3+ Ps Co-crystal
1QXS 18 Yes 1,3-biphospho-D-glyceric acid 1$ Ps Co-crystal

* The 'new Pi' site is defined as the site of the phosphate in 1GYP, which contains only phosphate and NAD.

&Only subunits A, B and C. The D-G3H molecule in subunit D occupies a different position that does not correspond to any previously reported phosphate position.

# Two subunits per asymmetric unit.

+ Two conformers in the structure. Subunit D has only conformer A, and its phosphate moiety binds in the 'Ps' site. Subunits B and C have both conformers at 50% occupancy; the phosphate moiety in conformer B binds in a site that is 2.5 to 2.8 Å from the 'new Pi' site.

$ Only one subunit (subunit C) binds the analogue. One of the phosphate moieties binds in the 'Ps' site. The other binds in a site that is 2.8 Å from the 'new Pi' site.

HHS Vulnerability Disclosure